Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2025 | Evaluating ctDNA as a biomarker in cervical cancer monitoring

Jyoti Mayadev • 2 Jun 2025
ASCO 2025
Cervical Cancer Gynecological Cancer
CALLA

Jyoti Mayadev, MD, University of California San Diego Medical Center, San Diego, CA, comments on the potential of circulating tumor DNA (ctDNA) as a clinical prognostic biomarker in the monitoring of locally advanced cervical cancer. While ctDNA has shown promising results across cancer types, its implementation into clinical practice requires careful evaluation to ensure it guides personalized patient treatment effectively. This interview took place at the 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jyoti Mayadev

The future of ctDNA as a prognostic biomarker in cervical cancer
0:49
The future of ctDNA as a prognostic biomarker in cervical cancer
Jyoti Mayadev • 2 Jun 2025
How will ctDNA and liquid biopsies be utilized in gynecological cancers?
0:51
How will ctDNA and liquid biopsies be utilized in gynecological cancers?
Jyoti Mayadev • 2 Jun 2025
Cervical cancer updates at ASCO 2025: OUTBACK and KEYNOTE-A18
1:16
Cervical cancer updates at ASCO 2025: OUTBACK and KEYNOTE-A18
Jyoti Mayadev • 2 Jun 2025
ctDNA detection and outcomes in the CALLA trial for cervical cancer
1:17
ctDNA detection and outcomes in the CALLA trial for cervical cancer
Jyoti Mayadev • 2 Jun 2025

Related Videos

The future of antibody-drug conjugates in endometrial cancer
1:10
The future of antibody-drug conjugates in endometrial cancer
Linda Mileshkin • 30 May 2026
B7-H4-directed ADC in endometrial versus ovarian cancer
0:43
B7-H4-directed ADC in endometrial versus ovarian cancer
Linda Mileshkin • 30 May 2026
Barriers to cervical cancer screening among rural women in India
0:54
Barriers to cervical cancer screening among rural women in India
Shailendra Dandge • 31 May 2026
A community-based model for cervical cancer screening uptake in rural India
8:39
A community-based model for cervical cancer screening uptake in rural India
Shailendra Dandge • 31 May 2026
The content of VJOncology is intended for healthcare professionals